首页|血红蛋白变异度与慢性肾脏病5期透析患者并发肺动脉高压的关系

血红蛋白变异度与慢性肾脏病5期透析患者并发肺动脉高压的关系

扫码查看
目的 探讨血红蛋白(Hb)变异度与慢性肾脏病(chronic kidney disease,CKD)5期透析患者并发肺动脉高压(pulmonary arterial hypertension,PAH)的关系。方法 回顾性分析2021年1月-2023年4月濮阳市人民医院97例CKD 5期透析患者的临床资料,根据肺动脉平均压水平将其分为PAH组(n=43)和non-PAH组(n=54)。于患者透析期间多次检测Hb水平,计算Hb变异度。采用二元logistic回归分析CKD 5期透析患者并发PAH的危险因素,绘制受试者工作特征(ROC)曲线分析Hb变异度对CKD 5期透析患者并发PAH的预测价值。结果 PAH组透析龄高于non-PAH组,左心房内径大于non-PAH组,差异有统计学意义(P<0。05)。PAH组和non-PAH组患者在Hb剩余标准差、Hb变异度6组占比方面比较,差异有统计学意义(P<0。05)。经二元logistic回归分析,透析龄、Hb变异度是CKD 5期透析患者并发PAH的危险因素(OR>1,P<0。05)。绘制ROC曲线,Hb变异度对CKD5期透析患者并发PAH具有一定预测价值(AUC=0。801,P<0。001)。结论 Hb变异度与CKD 5期透析患者并发PAH有关,可作为预测CKD 5期透析患者并发PAH的指标。
Relationship between hemoglobin variability and pulmonary arterial hypertension in patients with chronic kidney disease undergoing phase 5 dialysis
Objective To investigate the relationship between hemoglobin(Hb)variability and pulmonary arterial hy-pertension(PAH)in patients with chronic kidney disease(CKD)undergoing phase 5 dialysis.Methods A retrospec-tive analysis was conducted on the clinical data of 97 CKD stage 5 dialysis patients in hospitals from January 2021 to April 2023.They were divided into PAH group(n=43)and non-PAH group(n=54)based on the average pulmona-ry artery pressure levels.Hb levels were measured multiple times during dialysis,and Hb variability was calculated.Bi-nary logistic regression was used to analyze the risk factors of PAH in patients with CKD stage 5 dialysis,and the receiver operating characteristic(ROC)curve was drawn to analyze the predictive value of Hb variability for PAH in patients with CKD stage 5 dialysis.Results The dialysis age of PAH group was higher than that of non-PAH group,and the left atrial diameter was larger than that of non-PAH group,with a statistical significant difference(P<0.05).There was a statistical significant difference in the proportion of Hb residual standard deviation and Hb variability between the PAH group and the non-PAH group(P<0.05).According to binary logistic regression analysis,dialysis age and Hb varia-bility were risk factors for PAH in CKD stage 5 dialysis patients(OR>1,P<0.05).The Receiver operating character-istic and Hb variability had a certain predictive value for CKD 5 dialysis patients complicated with PAH(AUC=0.801,P<0.001).Conclusion Hb variability is related to the occurrence of PAH in CKD stage 5 dialysis patients,and can be used as a predictor of PAH in CKD stage 5 dialysis patients.

Chronic kidney diseaseHemoglobin variabilityHemodialysisPulmonary arterial hypertension

王念华、吴玉彩

展开 >

濮阳市人民医院肾内科,河南濮阳 457000

慢性肾脏病 血红蛋白变异度 血液透析 肺动脉高压

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(9)
  • 16